Skip to main content

Day: February 18, 2025

Aktsiaselts Infortar Investor Webinar introducing the results of the Q4 2024

Infortar will organize a webinar for investors on 25 February 2025 at 12:00 (EET) in Estonian and at 14:00 (EET) in English to introduce the fourth quarter 2024 results. The webinar will be attended by the Chairman of the Board of Infortar Ain Hanschmidt, the Managing Director of Infortar Martti Talgre and Investor Relations Manager Kadri Laanvee. The webinar will be hosted on the Microsoft Teams platform. Please note that to participate, no prior registration is required, and no reminder of the webinar will be sent. You can either participate by joining from your web browser or via Microsoft Teams application. When using a smart device to join the webinar, you first need to download the Microsoft Teams application from either Play Store or App Store. Please join the webinar via the following links: 25 February 2025 at 12:00 (EET) Estonian...

Continue reading

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept), a biologic used to treat eye disorders, including diseases which can lead to vision loss or blindness. The process to obtain regulatory approval is anticipated to be completed in the fourth quarter of 2025. “We are extremely pleased with this new step in the development of our biosimilar candidate to Eylea®, as better access will benefit patients and their caregivers,” said Joseph McClellan,...

Continue reading

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT06, Alvotech’s proposed biosimilar to Eylea® (aflibercept), a biologic used to treat eye disorders, including diseases which can lead to vision loss or blindness. The process to obtain regulatory approval is anticipated to be completed in the fourth quarter of 2025. “We are extremely pleased with this new step in the development of our biosimilar candidate to Eylea®, as better...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – DOWLAIS GROUP PLC – Ordinary Shares

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Dowlais...

Continue reading

Aurora Mobile’s JPush Integrates DeepSeek to Revolutionize Intelligent Push Services and Enhance User Engagement

SHENZHEN, China, Feb. 18, 2025 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that its flagship product, JPush, has successfully integrated DeepSeek, a cutting-edge large language model (LLM) known for its lightweight architecture and domain-specific optimizations. This integration marks a significant milestone in JPush’s evolution, enabling developers to deliver smarter, more personalized, and highly efficient push notifications to their users. Transforming Push Notifications with DeepSeek JPush has long been recognized as a leader in mobile push notification services, providing developers with reliable and high-performance solutions to engage users. With the integration of DeepSeek,...

Continue reading

Fortuna to release fourth quarter and full year 2024 financial results on March 5, 2025; Conference call at 12 p.m. Eastern time on March 6, 202

VANCOUVER, British Columbia, Feb. 18, 2025 (GLOBE NEWSWIRE) — Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) announces that it will release its financial statements and MD&A for the fourth quarter and full year 2024 on Wednesday, March 5, 2025, after the market closes.   A conference call to discuss the financial and operational results will be held on Thursday, March 6, 2025, at 9:00 a.m. Pacific time | 12:00 p.m. Eastern time. Hosting the call will be Jorge A. Ganoza, President and CEO, Luis D. Ganoza, Chief Financial Officer, Cesar Velasco, Chief Operating Officer – Latin America, and David Whittle, Chief Operating Officer – West Africa. Shareholders, analysts, media and interested investors are invited to listen to the live conference call by logging onto the webcast at: https://www.webcaster4.com/Webcast/Page/1696/52039...

Continue reading

DSV, 1151 – NOTICE OF ANNUAL GENERAL MEETING 2025

Notice of Annual General Meeting Notice is hereby given that the Annual General Meeting of DSV A/S will be held on:Thursday, 20 March 2025, at 14:00 CET, at DSV A/S’ registered office DSV A/SHovedgaden 630, 2640 Hedehusene, Denmark Doors open at 13:00 CETLight refreshments will be served before the Annual General Meeting (from 13:00 CET). 1     Agenda       1.   Report of the Board of Directors and the Executive Board on the Company’s activities in 2024      2.   Presentation of the 2024 Annual Report with the audit report for adoption       3.   Resolution on application of profits or covering of losses as per the adopted 2024 Annual Report      4.   Approval of the proposed remuneration of the Board of Directors for the financial year 2025      5.   Presentation and approval of the 2024 Remuneration Report      6.   Election...

Continue reading

Sparekassen Kronjylland, number one in customer satisfaction, signs Agillic to raise the bar

Press release, Copenhagen, 18 February 2025 Sparekassen Kronjylland, among Denmark’s ten largest financial institutions, is organised around making a positive difference for the customers with a defined purpose to build life-long relationships and help customers get the best of their finance. As a guarantee savings bank, they aim to leverage the flexibility of not having shareholders to also make a difference in the local communities by supporting associations, clubs, and cultural institutions.  Customer satisfaction is the most important metric to Sparekassen Kronjylland and whilst ranking number one within banking in Denmark, they push to constantly improve and deliver ever more relevant information and customer experiences. Trine Kastrup Berthelsen, Project Manager at Sparekassen Kronjylland explains: “Our promise to customers is financial...

Continue reading

iQIYI Announces Fourth Quarter and Fiscal Year 2024 Financial Results

BEIJING, Feb. 18, 2025 (GLOBE NEWSWIRE) — iQIYI, Inc. (Nasdaq: IQ) (“iQIYI” or the “Company”), a leading provider of online entertainment video services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2024.          Fourth Quarter 2024 HighlightsTotal revenues were RMB6.61 billion (US$906.0 million1), decreasing 14% year over year. Operating income was RMB285.4 million (US$39.1 million) and operating income margin was 4%, compared to operating income of RMB773.7 million and operating income margin of 10% in the same period in 2023. Non-GAAP operating income2 was RMB405.9 million (US$55.6 million) and non-GAAP operating income margin was 6%, compared to non-GAAP operating income of RMB927.8 million and non-GAAP operating income margin of 12% in the same period...

Continue reading

FLSmidth welcomes two new executives to lead its Mining Products and Service business lines

PRESS RELEASE 18 February 2025, Copenhagen, Denmark   Leading mining technology and service supplier FLSmidth announces the appointment of two new leaders to Group Executive Management. Julian Soles will join FLSmidth on 1 May 2025 as President, Mining Products Business Line and Toni Laaksonen will join the company in the coming months as President, Mining Service Business Line. Toni Laaksonen joins FLSmidth from Glaston Corporation, a technology, solutions and service provider for the glass processing industry where he is President and CEO. Under his leadership, the company has developed its service offerings and global customer support as well as increased service sales by restructuring the global sales and service organisation. Before joining Glaston, he held several business, sales and service leadership positions with Metso, Outotec,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.